MK-677 ibutamoren dosage protocol

MK-677 ibutamoren is dosed orally — once daily — with a biological half-life of approximately 24 hours. Clinical trials have used doses of 5 mg, 10 mg, and 25 mg per day. The dose-response curve, timing considerations, cycle length recommendations, and titration strategies are covered below.

MK-677 ibutamoren dosage: 10 mg vs 25 mg

The two most commonly used MK-677 ibutamoren dosages are 10 mg and 25 mg per day. Both produce measurable increases in GH and IGF-1, but they differ in magnitude and side effect profile.

For most users starting MK-677 for the first time, 10 mg is the recommended starting dose. It produces meaningful GH/IGF-1 elevation with significantly fewer side effects than 25 mg. Users who tolerate 10 mg well and want greater effects can increase to 25 mg after 2–4 weeks. Some users find that 12.5 mg or 15 mg provides the optimal balance between efficacy and tolerability — these intermediate doses are easily achieved by splitting capsules or using liquid MK-677.

MK-677 ibutamoren timing: best time to take ibutamoren

MK-677 has a 24-hour half-life, so it can be taken at any time of day with consistent blood levels. However, timing affects which side effects and benefits are most pronounced.

Before bed (evening dosing) is the most common approach. MK-677 amplifies the natural GH pulse that occurs during deep sleep, maximizing the sleep-quality benefit. The appetite increase — MK-677's most disruptive side effect — occurs while the user is asleep, which prevents it from driving excess caloric intake during waking hours. The Copinschi et al. study that showed 50% increases in deep sleep used evening dosing.

Morning dosing is preferred by users who experience lethargy or grogginess from MK-677. Some users report that evening dosing makes them too drowsy or groggy upon waking. Morning dosing shifts the peak appetite increase to the daytime, which can be problematic for those trying to control caloric intake, but may be more convenient for users who eat larger meals during the day.

With or without food — MK-677 can be taken on an empty stomach or with a meal. Some users report that taking it with food reduces the initial appetite spike and any nausea. Clinical trials did not specify fed vs fasted state, and absorption appears to be consistent regardless.

MK-677 ibutamoren cycle length

Unlike anabolic steroids or SARMs, MK-677 does not suppress endogenous testosterone and does not require post-cycle therapy (PCT). This allows for longer cycle lengths. Common approaches include 8–12 week cycles with 4 weeks off (the standard bodybuilding approach — time-limited to manage side effects like water retention and appetite), 16–24 week extended cycles (for users who tolerate MK-677 well and want sustained IGF-1 elevation for body recomposition or anti-aging), and continuous use (supported by the Nass et al. 2-year study showing no tolerance — appropriate for anti-aging or GH-deficiency contexts under medical supervision).

The primary argument for cycling off MK-677 is not receptor desensitization (which doesn't appear to occur) but rather insulin sensitivity management. Extended MK-677 use can reduce insulin sensitivity over time, and periodic breaks may allow insulin sensitivity to normalize. Users on longer cycles should monitor fasting blood glucose and HbA1c periodically.

MK-677 ibutamoren half-life

MK-677's biological half-life is approximately 24 hours, which is exceptionally long compared to injectable growth hormone secretagogues. GHRP-6 has a half-life of about 20 minutes. GHRP-2 is similar. Ipamorelin is approximately 2 hours. Sermorelin is 10–20 minutes. This means injectable secretagogues require multiple daily injections (typically 2–3x per day) to maintain elevated GH levels, while MK-677 achieves sustained elevation with a single daily oral dose. The 24-hour half-life also means steady-state blood levels are achieved after approximately 4–5 days of daily dosing.